Effects of blood pressure and glucose on endothelial function

被引：34

作者：

Cosentino F. ^{[1
,2
]}

Lüscher T.F. ^{[1
]}

机构：

[1] Cardiology and Cardiovascular Research, University Hospital, CH-8091 Zurich

[2] IRCCS Neuromed, Pozzilli, IS

来源：

Current Hypertension Reports | 2001年 / 3卷 / 1期

基金：

新加坡国家研究基金会;

关键词：

Nitric Oxide; Endothelial Dysfunction; Endothelial Function; Human Aortic Endothelial Cell; Endothelial Cell Dysfunction;

D O I：

10.1007/s11906-001-0085-8

中图分类号：

学科分类号：

摘要：

Hypertension and diabetes mellitus are associated with accelerated atherosclerosis and an increased prevalence of cardiovascular disease. Loss of the modulatory role of the endothelium can be considered the link between these conditions and cardiovascular disease. Substantial evidence suggests that vasodilation mediated by endothelium-derived nitric oxide (NO) is impaired in animal models and in patients with hypertension and diabetes mellitus. NO is a principal factor involved in the anti-atherosclerotic properties of the endothelium. Therefore, the pathogenesis of hypertensive and diabetic vascular disease may involve a reduced bioavailability of endothelium-derived NO. Inactivation of NO by reactive oxygen species is an important common mechanism by which endothelial dysfunction may occur. This review summarizes experimental and clinical evidence for impaired NO-mediated vasodilation in the presence of high blood pressure and hyperglycemia. A better understanding of the mechanisms leading to endothelial dysfunction may unmask new preventive strategies to reduce cardiovascular morbility and mortality in these conditions. Copyright © 2001 by Current Science Inc.

引用

页码：79 / 88

页数：9

共 55 条

[21]

Egashira K., Suzuki S., Hirooka Y., Et al., Impaired endotheliumdependent vasodilation of large epicardial and resistance coronary arteries in patients with essential hypertension, Circulation, 25, pp. 201-206, (1995)

[22]

Li J., Zaho S.P., Li X.P., Et al., Non-invasive detection of endothelial dysfunction in patients with essential hypertension, Int J Cardiol, 61, pp. 165-169, (1997)

[23]

Forte P., Copland M., Smith L.M., Et al., Basal nitric oxide synthesis in essential hypertension, Lancet, 349, pp. 837-842, (1997)

[24]

Cockroft J.R., Chowienczyck P.J., Benjamin N., Et al., Preserved endothelium-dependent vasodilation in patients with essential hypertension, N Engl J Med, 300, pp. 1036-1040, (1994)

[25]

Brunig T.A., Chang P.C., Hendricks G.C., Et al., In vivo characterization of muscarinic receptors subtypes that mediate vasodilation in patients with essential hypertension, Hypertension, 26, pp. 70-77, (1995)

[26]

Taddei S., Virdis A., Mattei P., Et al., Vasodilation to acetylcholine in primary and secondary forms of hypertension, Hypertension, 21, pp. 929-933, (1993)

[27]

Taddei S., Virdis A., Mattei P., Et al., Hypertension causes premature aging of endothelial function in humans, Hypertension, 29, pp. 736-743, (1997)

[28]

Taddei S., Virdis A., Ghiadoni L., Et al., Cyclooxygenase inhibition restores nitric oxide activity in essential hypertension, Hypertension, 29, pp. 274-279, (1997)

[29]

Solzbach U., Horning B., Jeserisch M., Et al., Vitamin C improves endothelial dysfunction of epicardial coronary arteries in hypertensive patients, Circulation, 96, pp. 1513-1519, (1997)

[30]

Taddei S., Virdis A., Mattei P., Et al., Defective l-arginine-nitric oxide pathway in offspring of essential hypertensive patients, Circulation, 94, pp. 1298-1303, (1996)

← 1 2 3 4 5 6 →